Literature DB >> 25491378

Insulin-like growth factor-I and insulin-like growth factor binding protein-1 are related to cardiovascular disease biomarkers in obese adolescents.

Lorraine E Levitt Katz1, Kevin A Gralewski1, Pamela Abrams2, Preneet C Brar3, Paul R Gallagher4, Terri H Lipman1, Lee J Brooks5, Dorit Koren6.   

Abstract

CONTEXT: Insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 have been linked to cardiovascular disease (CVD) risk and pathophysiology in adults, but there are limited data in youth.
OBJECTIVE: The aim of the study was to examine the relationship between IGF and IGFBP-1 with traditional and non-traditional CVD risk factors including inflammatory markers and body composition in an obese pediatric cohort.
DESIGN: A cross-sectional study.
SETTING: The study was carried out at a university children's hospital.
SUBJECTS: Sixty-one obese non-diabetic adolescents. OUTCOMES: Fasting IGF-I, IGFBP-1, lipoprotein profiles, high-sensitivity C-reactive protein (hsCRP), and total adiponectin as well as insulin sensitivity measures, blood pressure (BP), and anthropometrics.
RESULTS: IGFBP-1 was negatively associated with insulin sensitivity measures, body mass index (BMI), and diastolic BP in males. IGF-I was negatively associated with hsCRP (r = -0.479, p < 0.0005), and IGFBP-1 was positively associated with adiponectin (r = 0.545, p < 0.0005). The IGF-I/CRP and IGFBP-1/adiponectin associations remained significant when controlling for both BMI and insulin sensitivity index (SI ). Both IGF-I and IGFBP-1 were negatively associated with waist circumference (r = -0.327 and r = -0.275, respectively) and sagittal abdominal diameter (r = -0.333 and r = -0.371, respectively), while IGFBP-1 was negatively associated with fat mass (r = -0.347, p = 0.01) as well as neck circumference and fat-free mass in males. Controlling for BMI z-score and SI , IGFBP-1 remained negatively associated with diastolic blood pressure (r = 0.706, p = 0.001 and neck circumference (r = -0.548, p = 0.15) in males.
CONCLUSIONS: IGF-I and IGFBP-1 associate with CVD risk markers and may add to clinical assessments of cardiometabolic dysfunction in youth.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CVD risk factors; IGF-I; IGFBP-1; adiponectin; neck circumference

Mesh:

Substances:

Year:  2014        PMID: 25491378      PMCID: PMC4608856          DOI: 10.1111/pedi.12242

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  56 in total

1.  The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity.

Authors:  Ping Wang; Ning Li; Jie-Shou Li; Wei-Qin Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

2.  Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.

Authors:  E Shahar; C W Whitney; S Redline; E T Lee; A B Newman; F J Nieto; G T O'Connor; L L Boland; J E Schwartz; J M Samet
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

3.  Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations.

Authors:  A H Heald; J K Cruickshank; L K Riste; J E Cade; S Anderson; A Greenhalgh; J Sampayo; W Taylor; W Fraser; A White; J M Gibson
Journal:  Diabetologia       Date:  2001-03       Impact factor: 10.122

4.  Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.

Authors:  Subodh Verma; Shu-Hong Li; Mitesh V Badiwala; Richard D Weisel; Paul W M Fedak; Ren-Ke Li; Bikramjit Dhillon; Donald A G Mickle
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

5.  The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome.

Authors:  Kalpana Kaushal; Adrian H Heald; Kirk W Siddals; Manjinder S Sandhu; David B Dunger; John M Gibson; Nick J Wareham
Journal:  Diabetes Care       Date:  2004-11       Impact factor: 19.112

6.  Threshold values of visceral fat measures and their anthropometric alternatives for metabolic derangement in Japanese obese boys.

Authors:  K Asayama; K Dobashi; H Hayashibe; K Kodera; N Uchida; T Nakane; T Araki; S Nakazawa
Journal:  Int J Obes Relat Metab Disord       Date:  2002-02

7.  Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version.

Authors:  Cynthia L Ogden; Robert J Kuczmarski; Katherine M Flegal; Zuguo Mei; Shumei Guo; Rong Wei; Laurence M Grummer-Strawn; Lester R Curtin; Alex F Roche; Clifford L Johnson
Journal:  Pediatrics       Date:  2002-01       Impact factor: 7.124

8.  Free and total insulin-like growth factor (IGF)-I levels decline during fasting: relationships with insulin and IGF-binding protein-1.

Authors:  Lorraine E L Katz; Diva D DeLeón; Hui Zhao; Abbas F Jawad
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

9.  Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study.

Authors:  Anders Juul; Thomas Scheike; Michael Davidsen; Jesper Gyllenborg; Torben Jørgensen
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

Review 10.  Obstructive sleep apnea and type 2 diabetes: interacting epidemics.

Authors:  Esra Tasali; Babak Mokhlesi; Eve Van Cauter
Journal:  Chest       Date:  2008-02       Impact factor: 9.410

View more
  3 in total

1.  Fasting Serum IGFBP-1 as a Marker of Insulin Resistance in Diverse School Age Groups.

Authors:  Amrit Bhangoo; Rishi Gupta; Steve P Shelov; Dennis E Carey; Siham Accacha; Ilene Fennoy; Lisa Altshuler; Barbara Lowell; Robert Rapaport; Warren Rosenfeld; Phyllis W Speiser; Svetlana Ten; Michael Rosenbaum
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-02       Impact factor: 6.055

Review 2.  A Functional Interplay between IGF-1 and Adiponectin.

Authors:  Stefania Orrù; Ersilia Nigro; Annalisa Mandola; Andreina Alfieri; Pasqualina Buono; Aurora Daniele; Annamaria Mancini; Esther Imperlini
Journal:  Int J Mol Sci       Date:  2017-10-14       Impact factor: 5.923

3.  Left Ventricular Geometrical Changes in Severely Obese Adolescents: Prevalence, Determinants, and Clinical Implications.

Authors:  Ali Talib; Yvonne G M Roebroek; Givan F Paulus; Kris van Loo; Bjorn Winkens; Nicole D Bouvy; Ernst L W E van Heurn
Journal:  Pediatr Cardiol       Date:  2020-10-20       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.